Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05302752
Other study ID # REMEX-WP1
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 13, 2022
Est. completion date December 2027

Study information

Verified date March 2024
Source Swiss Federal Institute of Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this project the quantification and the repeatability of responses to rapid bilateral magnetic stimulation of the phrenic nerves will be investigated in healthy humans.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 16
Est. completion date December 2027
Est. primary completion date December 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: - healthy - non-smoking - normal lung function - body mass index: 18.5-29.9 kg/m2 - able to communicate in english - willing to adhere to study rules Exclusion Criteria: - acute illness or chronic conditions of the gastrointestinal tract, and health conditions affecting metabolism, the cardiovascular or the respiratory system, or sleep - intake of medications affecting metabolism, the cardiovascular, the neuromuscular or the respiratory system, or sleep - any metal or electronics inside of the body - presence of cardiac pacemaker, implanted defibrillators or implanted neurostimulators - history of seizures or epilepsy - tatoos on the stimulation sites - previous enrolment in this study - for women: pregnancy, breastfeeding, or intention to become pregnant during the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Magnetic phrenic nerve stimulation
The intervention consists of bilateral rapid magnetic phrenic nerve stimulation on the neck using different stimulation intensities. On one visit, the effect of increasing chest wall stiffness and respiratory muscle work by adding incrementally small weights to the chest/abdomen will be investigated.

Locations

Country Name City State
Switzerland Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
Swiss Federal Institute of Technology

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Other Changes in airflow Flow will be recorded by a pneumotachometer and averaged over breaths. Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
Other Changes in chest and abdominal movements Chest and abdominal movements will be assessed using respiratory belt strain transducers. Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
Other Changes in costal diaphragm activity Costal diaphragm activity will be continuously recorded via a wireless surface electromyography system. Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
Other Head, shoulder and arm accelerations Head, shoulder and arm movements will be recorded using wireless acceleration sensors attached to the head and arms. Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
Other Body movement Overall body movement incl. head, shoulder and arm movements will be recorded using a video camera. Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
Other Changes in skin conductance Skin conductance (µS) will be continuously recorded with electrodes worn on two fingers. Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
Other Changes in heart rate Heart rate will will be continuously recorded beat by beat (1/min) with electrodes on both wrists and one ankle. Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
Other Changes in blood pressure Systolic and diastolic blood pressure (mmHg) will be continuously recorded using a non-invasive device. Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
Other Perception of pain, paresthesia and discomfort Participant subject perception of pain, paresthesia and discomfort will be evaluated with 0-to-10-point scale, with 0 = no pain/paresthesia/discomfort and 10 = maximal pain/paresthesia/discomfort. Higher values indicate more perception of the specified sensations. Assessed 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
Primary Diaphragm contractility Transdiaphragmatic pressure changes, i.e. changes in esophageal and gastric pressures, will be measured by a pressure transducer connected to balloon-catheters. Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1